Loading...

Emerging markets still a good bet, Abbott

Image

22-Oct-15 Although growth in emerging markets is slowing, Abbott CEO Miles White remains upbeat about the prospects in countries like China. During 3Q 2015, Abbott saw revenue in emerging markets soar 21%. “Policies focused on expanding access to care and favorable trends, including increasing birth rates, aging populations, and adoption of Western standards and technologies, are all driving growth,” said White. [image: MD + DI].

Read More

AstraZeneca opens new manufacturing facility to support continued growth in Russia

Image

20-Oct-15 AstraZeneca announced a new state-of-the-art manufacturing and packaging facility in Kaluga, Russia, dedicated to the local supply of innovative medicines. In 2011 AstraZeneca was one of the first multinational pharmaceutical companies to announce plans to invest in the construction of a dedicated manufacturing facility in Russia. Four years on, the Company has invested USD224m. [image: AstraZeneca]

Read More

Japan establishes cardiac imaging training centre in Russia

Image

09-Sep-15 Medical Excellence Japan in collaboration with Toshiba Medical Systems has established a Russia-Japan cardiac imaging training centre, which will provide services to improve cardiac diagnostic imaging in Russia. The project is one of the programmes conducted by the Ministry of Economy, Trade and Industry in 2013 to promote and accelerate the medical globalisation. [image: Medical Device Network]

Read More

Addressing Western medtech design bias in emerging markets

Image

08-Jul-15 Emerging markets are the medtech industry’s best prospects for growth, but most medical devices are still designed in the US and Europe. That can present a problem when companies try to adapt devices or develop new devices for non-Western markets, which may have different cultural, financial, and other considerations that can affect the success of a product. [image: University of Minnesota]

Read More

Merck flaunts Russian expansion

Image

18-Jun-15 Merck's Russian expansion drive remains unaltered, its top executives say, despite a looming recession, a state localization drive, and deteriorating relations with the West. Merck is increasing headcount and expects to improve on its EUR150 mn sales of 2014. "It is crucial to capture the niche markets," said Jurgen Konig, head of Merck in Russia. [image: Armin Kübelbeck / Wikicommons]

Read More
Share